NASDAQ: SNDXSyndax Pharmaceuticals Inc Stock Ownership - Who owns Syndax Pharmaceuticals?
Insider buying vs selling
Have Syndax Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Keith A. Goldan | Chief Financial Officer | 2024-01-31 | 1,183 | $17.42 | $20.61kBuy |
| Briggs Morrison | Director | 2023-08-09 | 52,855 | $18.27 | $965.40kSell |
| Briggs Morrison | Director | 2023-08-09 | 52,855 | $8.77 | $463.54kBuy |
| William Meury | Director | 2023-08-02 | 24,000 | $20.46 | $490.92kSell |
| William Meury | Director | 2023-08-02 | 24,000 | $9.47 | $227.28kBuy |
| William Meury | Director | 2023-08-02 | 24,000 | $20.46 | $490.94kSell |
| William Meury | Director | 2023-08-02 | 24,000 | $7.88 | $189.12kBuy |
| William Meury | Director | 2023-08-02 | 35,000 | $20.46 | $715.96kSell |
| William Meury | Director | 2023-08-02 | 35,000 | $7.11 | $248.85kBuy |
| Keith A. Goldan | Chief Financial Officer | 2023-07-31 | 862 | $18.12 | $15.62kBuy |
SNDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SNDX insiders and whales buy or sell their stock.
SNDX Shareholders
What type of owners hold Syndax Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Wellington Management Group LLP | 8.93% | 7,585,221 | $157.70M | Institution |
| Blackrock Inc | 8.26% | 7,015,548 | $145.85M | Institution |
| Kynam Capital Management LP | 6.66% | 5,660,000 | $117.67M | Institution |
| State Street Corp | 5.90% | 5,016,224 | $104.29M | Institution |
| Vanguard Group Inc | 5.10% | 4,335,353 | $90.13M | Institution |
| Avoro Capital Advisors LLC | 4.97% | 4,222,222 | $87.78M | Institution |
| Avidity Partners Management LP | 4.65% | 3,950,000 | $82.12M | Institution |
| Eversept Partners LP | 3.98% | 3,383,244 | $70.34M | Institution |
| Point72 Asset Management LP | 3.34% | 2,834,499 | $58.93M | Institution |
| T Rowe Price Investment Management Inc | 3.19% | 2,711,253 | $56.37M | Institution |
SNDX vs Biotech Stocks
Syndax Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.